{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:42:45Z","timestamp":1788903765930,"version":"build-2803163510"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11096-019-00915-2","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T06:37:46Z","timestamp":1570516666000},"page":"1526-1535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Outpatient benzodiazepine utilization in Croatia: drug use or misuse"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-0216","authenticated-orcid":false,"given":"Marija","family":"Dela\u0161 A\u017edaji\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Liki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stjepan","family":"A\u017edaji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna","family":"\u0160itum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Lovri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"\u0160timac Grbi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,8]]},"reference":[{"key":"915_CR1","unstructured":"World Health Organization. Mental health action plan 2013\u20132020. Geneva, Switzerland. 2013. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/89966\/9789241506021_eng.pdf?sequence=1 . Accessed 6 Aug 2018."},{"key":"915_CR2","doi-asserted-by":"crossref","unstructured":"OECD\/EU. Health at a Glance: Europe: State of Health in the EU Cycle, OECD Publishing, Paris, 2018. doi: 10.1787\/health_glance_eur-2018-en.","DOI":"10.1787\/health_glance_eur-2018-en"},{"key":"915_CR3","unstructured":"Eurostat. Mental health and related issues statistics. https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php\/Mental_health_and_related_issues_statistics . Accessed 14 Feb 2019."},{"key":"915_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.genhosppsych.2010.12.004","volume":"33","author":"L Spanemberg","year":"2011","unstructured":"Spanemberg L, Nogueira EL, da Silva CT, Darg\u00e9l AA, Menezes FS, Cataldo Neto A. High prevalence and prescription of benzodiazepines for elderly: data from psychiatric consultation to patients from an emergency room of a general hospital. Gen Hosp Psychiatr. 2011;33:45\u201350.","journal-title":"Gen Hosp Psychiatr"},{"key":"915_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/089198870001300309","volume":"13","author":"MD Llorente","year":"2000","unstructured":"Llorente MD, David D, Golden AG, Silverman MA. Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatr Neurol. 2000;13:150\u201360.","journal-title":"J Geriatr Psychiatr Neurol"},{"key":"915_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1590\/S1516-44462002000200006","volume":"24","author":"AR Noto","year":"2002","unstructured":"Noto AR, Carlini EA, Mastroianni PC, Alves VC, Galduroz JC, Kuroiwa W, et al. Analysis of prescription and dispensation of psychotropic medications in two cities in the State of S\u00e3o Paulo, Brazil. Braz J Psychiatr. 2002;24:68\u201373.","journal-title":"Braz J Psychiatr"},{"key":"915_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1590\/S0034-89102006000100017","volume":"40","author":"MA Rodrigues","year":"2006","unstructured":"Rodrigues MA, Facchini LA, Lima MS. Modifica\u00e7\u00f5es nos padr\u00f5es de consumo de psicof\u00e1rmacos em localidade do Sul do Brasil. Rev Saude Publica. 2006;40:107\u201314.","journal-title":"Rev Saude Publica"},{"key":"915_CR8","first-page":"717","volume":"38","author":"K \u017divkovi\u0107","year":"2014","unstructured":"\u017divkovi\u0107 K, Zeli\u0107 A, \u0160timac D, O\u017ei\u0107 S, \u017divkovi\u0107 N. A study on the quality of outpatient prescription of psychopharmaceuticals in the City of Zagreb 2006\u20132009. Coll Antropol. 2014;38:717\u201324.","journal-title":"Coll Antropol"},{"key":"915_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40545-017-0128-4","volume":"11","author":"MAF Garc\u00eda","year":"2018","unstructured":"Garc\u00eda MAF, de Labry Lima AO, Ferrer Lopez I, Berm\u00fadez-Tamayo C. Analysis of changes in trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs. J Pharm Policy Pract. 2018;11:1.","journal-title":"J Pharm Policy Pract"},{"key":"915_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/NDT.S4234","volume":"5","author":"R Hardeland","year":"2009","unstructured":"Hardeland R. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. Neuropsychiatr Dis Treat. 2009;5:341\u201354.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"915_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00228-011-1188-z","volume":"68","author":"J Bourgeois","year":"2012","unstructured":"Bourgeois J, Elseviers MM, Azermai M, van Bortel L, Petrovic M, Vander Stichele RR. Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. Eur J Clin Pharmacol. 2012;68:833\u201344.","journal-title":"Eur J Clin Pharmacol"},{"key":"915_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/13651500903447810","volume":"14","author":"J Donoghue","year":"2010","unstructured":"Donoghue J, Lader M. Usage of benzodiazepines: a review. Int J Psychiatry Clin Pract. 2010;14:78\u2013877.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"915_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TA Kurko","year":"2015","unstructured":"Kurko TA, Saastamoinen LK, Tahkapaa S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, et al. Longterm use of benzodiazepines: definitions, prevalence and usage patterns\u2014a systematic review of register-based studies. Eur Psychiatry. 2015;30:1037\u201347.","journal-title":"Eur Psychiatry"},{"key":"915_CR14","unstructured":"Benzodiazepine Committee. Benzodiazepines: good practice guidelines for clinicians. Dublin: Department of Health and Children. 2002. https:\/\/health.gov.ie\/wp-content\/uploads\/2014\/04\/Benzodiazepines-Good-Practice-Guidelines.pdf . Accessed 12 Aug 2018."},{"key":"915_CR15","first-page":"37","volume":"18","author":"MJ Barker","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol. 2004;18:37\u201348.","journal-title":"Arch Clin Neuropsychol"},{"key":"915_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2165\/00023210-200317110-00004","volume":"17","author":"RG Cumming","year":"2003","unstructured":"Cumming RG, Le Conteur DG. Benzodiazepines and risk of hip fractures in older people. CNS Drugs. 2003;17:825\u201337.","journal-title":"CNS Drugs"},{"key":"915_CR17","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M. Benzodiazepines revisited\u2014will we ever learn? Addiction. 2011;106:2086\u2013109.","journal-title":"Addiction"},{"key":"915_CR18","doi-asserted-by":"publisher","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"SB De Gage","year":"2014","unstructured":"De Gage SB, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, et al. Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ. 2014;349:g5205.","journal-title":"BMJ"},{"key":"915_CR19","doi-asserted-by":"publisher","first-page":"g5312","DOI":"10.1136\/bmj.g5312","volume":"349","author":"K Yaffe","year":"2014","unstructured":"Yaffe K, Boustani M. Benzodiazepines and risk of Alzheimer\u2019s disease. BMJ. 2014;349:g5312.","journal-title":"BMJ"},{"key":"915_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3399\/bjgp08X299290","volume":"58","author":"AN Siriwardena","year":"2008","unstructured":"Siriwardena AN, Qureshi MZ, Dyas JV, Middleton H, Orner R. Magic bullets for insomnia? Patients\u2019 use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. Br J Gen Pract. 2008;58:417\u201322.","journal-title":"Br J Gen Pract"},{"key":"915_CR21","first-page":"S26","volume":"7","author":"V Peritogiannis","year":"2016","unstructured":"Peritogiannis V, Manthopoulou T, Mavreas V. Long-term benzodiazepine treatment in patients with psychotic disorders attending a mental health service in rural Greece. J Neurosci Rural Pract. 2016;7:S26\u2013S30.","journal-title":"J Neurosci Rural Pract"},{"key":"915_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/gps.2189","volume":"24","author":"K Johnell","year":"2009","unstructured":"Johnell K, Fastbom J. The use of benzodiazpines and related drugs amongst older people in Sweden: associated factors and concomitant use of other psychotropics. Int J Geriatr Psychiatr. 2009;24:731\u20138.","journal-title":"Int J Geriatr Psychiatr"},{"key":"915_CR23","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/pds.2013","volume":"19","author":"F Hoffmann","year":"2010","unstructured":"Hoffmann F, Hies M, Glaeske G. Regional variations of private prescriptions for the non-benzodiazepine hypnotics zolpidem and zopiclone in Germany. Pharmacoepidemiol Drug Saf. 2010;19:1071\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"915_CR24","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.9778\/cmajo.20160056","volume":"5","author":"D Weymann","year":"2017","unstructured":"Weymann D, Gladstone EJ, Smolina K, Morgan SG. Longterm sedative use among community-dwelling adults: a population-based analysis. CMAJ Open. 2017;5:E52\u2013E60.","journal-title":"CMAJ Open"},{"key":"915_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/0023210-200923010-00002","volume":"23","author":"M Lader","year":"2009","unstructured":"Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23:19\u201334.","journal-title":"CNS Drugs"},{"key":"915_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MLR.0b013e3181ef9a7e","volume":"49","author":"R Ostini","year":"2011","unstructured":"Ostini R, Jackson C, Hegney D, Tett SE. How is medication prescribing ceased? A systematic review. Med Care. 2011;49:24\u201336.","journal-title":"Med Care"},{"key":"915_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/YCO.0b013e32831a473d","volume":"22","author":"J Cloos","year":"2009","unstructured":"Cloos J, Ferreira V. Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatr. 2009;22:90\u20135.","journal-title":"Curr Opin Psychiatr"},{"key":"915_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1192\/bjp.189.3.213","volume":"189","author":"RC Voshaar","year":"2006","unstructured":"Voshaar RC, Couvee JE, van Balkom AJ, Mulder PG, Zitman FG. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatr. 2006;189:213\u201320.","journal-title":"Br J Psychiatr"},{"key":"915_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2165\/00003495-199448010-00004","volume":"48","author":"H Ashton","year":"1994","unstructured":"Ashton H. Guidelines for the rational use of benzodiazepines\u2014when and what to use. Drugs. 1994;48:25\u201340.","journal-title":"Drugs"},{"key":"915_CR30","unstructured":"Canadian Agency for Drugs and Technologies in Health. Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines. 2010. https:\/\/www.cadth.ca\/media\/pdf:M0022_Benzodiazepines_Elderly.pdf . Accessed 3 Feb 2019."},{"key":"915_CR31","unstructured":"National Institute for Health and Clinical Excellence. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. 2011. https:\/\/www.nice.org.uk\/nicemedia\/live\/13314\/52599\/52599.pdf . Accessed 12 Aug 2018."},{"issue":"7","key":"915_CR32","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1177\/0269881107077355","volume":"21","author":"JL Martin","year":"2007","unstructured":"Martin JL, Sainz-Pardo M, Furukawa TA, Martin-Sanchez E, Seoane T, Galan C. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol. 2007;21(7):774\u201382.","journal-title":"J Psychopharmacol"},{"key":"915_CR33","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/gps.2623","volume":"26","author":"SG B\u00e9land","year":"2011","unstructured":"B\u00e9land SG, Pr\u00e9ville M, Dubois MF, Lorrain D, Voyer P, Boss\u00e9 C, et al. Scientific committee of the ESA study: the association between length of benzodiazepine use and sleep quality in older population. Int J Geriatr Psychiatr. 2011;26:908\u201315.","journal-title":"Int J Geriatr Psychiatr"},{"key":"915_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/1472-6963-14-343","volume":"14","author":"M Poli\u0107-Vi\u017eintin","year":"2014","unstructured":"Poli\u0107-Vi\u017eintin M, \u0160timac D, \u0160ostar Z, Tripkovi\u0107 I. Distribution and trends in outpatient utilization of generic versus brand name psychopharmaceuticals during a ten-year period in Croatia. BMC Health Serv Res. 2014;14:343.","journal-title":"BMC Health Serv Res"},{"key":"915_CR35","unstructured":"Ministry of Health. Pravilnik o mjerilima za razvrstavanje lijekova te o propisivanju i izdavanju lijekova na recept, Zagreb, NN 86\/2013. 90\/2013. https:\/\/narodne-novine.nn.hr\/clanci\/sluzbeni\/2013_07_86_1937.html . Accessed 12 Aug 2018."},{"key":"915_CR36","unstructured":"Hrvatski zavod za zdravstveno osiguranje. Arhiva liste Lijekova. https:\/\/www.hzzo.hr\/zdravstveni-sustav-rh\/trazilica-za-lijekove-s-vazecih-lista\/arhiva-liste-lijekova\/ . Accessed 28 Jun 2019."},{"key":"915_CR37","volume-title":"Benzodiazepini u suvremenoj medicini","author":"M Jakovljevi\u0107","year":"2001","unstructured":"Jakovljevi\u0107 M, Lackovi\u0107 Z. Benzodiazepini u suvremenoj medicini. 1st ed. Zagreb: Medicinska naklada; 2001.","edition":"1"},{"key":"915_CR38","volume-title":"Farmakoterapijski priru\u010dnik","author":"I Franceti\u0107","year":"2015","unstructured":"Franceti\u0107 I. Farmakoterapijski priru\u010dnik. Zagreb: Medicinska naklada; 2015."},{"key":"915_CR39","volume-title":"Klini\u010dka farmakologija","author":"I Franceti\u0107","year":"2014","unstructured":"Franceti\u0107 I, Vitezi\u0107 D. Klini\u010dka farmakologija. 2nd ed. Zagreb: Medicinska naklada; 2014.","edition":"2"},{"key":"915_CR40","unstructured":"WHO Collaborating Centre for Drug Statistics methodology. https:\/\/www.whocc.no\/atc_ddd_index\/ . Accessed 10 Sep 2018."},{"key":"915_CR41","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision. https:\/\/apps.who.int\/classifications\/icd10\/browse\/2016\/en . Accessed 11 Sep 2018."},{"key":"915_CR42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1472-8206.2010.00906.x","volume":"26","author":"F Rouby","year":"2012","unstructured":"Rouby F, Pradel V, Frauger E, Pauly V, Natali F, Reggio P, et al. Assessment of abuse of tianeptine from a reimbursement database using 'doctor-shopping' as an indicator. Fundam Clin Pharmacol. 2012;26:286\u201394.","journal-title":"Fundam Clin Pharmacol"},{"key":"915_CR43","unstructured":"Croatian Bureau of Statistics. Census of Population, Households and Dwellings in the Republic of Croatia in 2011. https:\/\/www.dzs.hr . Accessed 11 Sep 2018."},{"key":"915_CR44","unstructured":"Croatian Bureau of Statistics. 48th Statistical Yearbook of the Republic of Croatia. 2016. https:\/\/www.dzs.hr\/ . Accessed 11 Sep 2018."},{"issue":"S2","key":"915_CR45","first-page":"67","volume":"38","author":"\u017d Vojvodi\u0107","year":"2014","unstructured":"Vojvodi\u0107 \u017d, Nelken-Bestvina D, Kurc- Bionda A, \u0160timac D. Trends in prescribing in primary care in Croatia, 2000\u20132012: prescribing volume, costs and regulatory measures. Coll Antropol. 2014;38(S2):67\u201372.","journal-title":"Coll Antropol"},{"key":"915_CR46","unstructured":"IMS Institute for Healthcare Informatics. Global Use of Medicines in 2020. Outlook and Implications. 2015. https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/institute-reports\/global-medicines-use-in-2020 . Accessed 14 Feb 2019."},{"key":"915_CR47","unstructured":"Agencija za lijekove i medicinske proizvode\u2014HALMED. Potro\u0161nja lijekova u Hrvatskoj 2012\u20132016. https:\/\/www.halmed.hr\/fdsak3jnFsk1Kfa\/publikacije\/Potrosnja-lijekova-u-RH_2012-2016.pdf . Accessed 15 Oct 2018."},{"key":"915_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00019053-199202050-00007","volume":"2","author":"JS Lyons","year":"1992","unstructured":"Lyons JS, Larson DB, Hromco J. Clinical and economic evaluation of benzodiazepines: a value analysis. Pharmacoeconomics. 1992;2:397\u2013407.","journal-title":"Pharmacoeconomics"},{"key":"915_CR49","unstructured":"United Nations. Psychotropic Substances 2018\u2014Statistics for 2017. https:\/\/www.incb.org\/documents\/Psychotropics\/technical-publications\/2018\/PSY_Technical_Publication_2018.pdf . Accessed 26 Mar 2019."},{"key":"915_CR50","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","volume":"73","author":"E Reeve","year":"2017","unstructured":"Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol. 2017;73:927\u201335.","journal-title":"Eur J Clin Pharmacol"},{"key":"915_CR51","unstructured":"World Health Organization. Mental health-data and resources https:\/\/www.euro.who.int\/en\/health-topics\/noncommunicable-diseases\/mental-health\/data-and-resources . Accessed 31 Jan 2019."},{"key":"915_CR52","unstructured":"Organisation for Economic Co-operation and Development. OECD\/EU database. 2018. https:\/\/stats.oecd.org\/index.aspx?DataSetCode=HEALTH_STAT . Accessed 31 Jan 2019."},{"key":"915_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.20344\/amp.10683","volume":"32","author":"J Urzal","year":"2019","unstructured":"Urzal J, Pedro AB, Oliveira IF, Romero I, Achega M, Correia I, et al. Inappropriate prescribing to elderly patients in an internal medicine ward. Acta Med Port. 2019;32:141\u20138.","journal-title":"Acta Med Port"},{"key":"915_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4321\/S1135-57272013000300004","volume":"87","author":"V S\u00e1nchez","year":"2013","unstructured":"S\u00e1nchez V, Pilar M, Mac\u00edas Saint-Gerons D, Cdela FH, Gonz\u00e1lez Bermejo D, Montero Corominas D et al. Evoluci\u00f3n del uso de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a durante el per\u00edodo 2000\u20132011. Revista Espa\u00f1ola de Salud P\u00fablica. 2013;87:247\u201355.","journal-title":"Revista Espa\u00f1ola de Salud P\u00fablica"},{"key":"915_CR55","unstructured":"The Agency for Medicinal Products and Medical Devices (Croatia). Ukupna potro\u0161nja lijekova u 2016. Godini. https:\/\/halmed.hr\/fdsak3jnFsk1Kfa\/ostale_stranice\/Tablica_16-Ukupna_potrosnja_lijekova_u_2016_godini.pdf . Accessed 31 Jan 2019."},{"key":"915_CR56","unstructured":"The Agency for Medicinal Products and Medical Devices (Croatia). Ukupna potro\u0161nja lijekova u 2015. Godini. https:\/\/halmed.hr\/fdsak3jnFsk1Kfa\/ostale_stranice\/Tablica_16-Ukupna_potrosnja_lijekova_u_2015_godini.pdf . Accessed 31 Jan 2019."},{"key":"915_CR57","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00228-016-2044-y","volume":"72","author":"A B\u00e9nard-Laribi\u00e8re","year":"2016","unstructured":"B\u00e9nard-Laribi\u00e8re A, Noize P, Pambrun E, Bazin F, Verdoux H, Tournier M, et al. Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users. Eur J Clin Pharmacol. 2016;72:869\u201376.","journal-title":"Eur J Clin Pharmacol"},{"key":"915_CR58","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/pds.641","volume":"10","author":"C Barbui","year":"2001","unstructured":"Barbui C. Drug epidemiology in Italy: methods and ethical issues: The example of psychiatry. Pharmacoepidemiol Drug Saf. 2001;10:647\u201352.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"915_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/105931","author":"JTM van Eijk","year":"2010","unstructured":"van Eijk JTM, Bosma H, Jonkers CCM, Lamers F, Muijrers PEM. Prescribing Antidepressants and benzodiazepines in the Netherlands: is chronic physical illness involved? Depress Res Treat. 2010. https:\/\/doi.org\/10.1155\/2010\/105931 .","journal-title":"Depress Res Treat"},{"key":"915_CR60","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1192\/bjp.bp.114.149252","volume":"205","author":"V Kapil","year":"2014","unstructured":"Kapil V, Green JL, Le Lait C, Wood DM, Dargan PI. Misuse of benzodiazepines and Z-drugs in the UK. Br J Psychiatr. 2014;205:407\u20138.","journal-title":"Br J Psychiatr"},{"key":"915_CR61","doi-asserted-by":"publisher","first-page":"446","DOI":"10.26719\/2012.18.5.446","volume":"18","author":"H Naqvi","year":"2012","unstructured":"Naqvi H, Sabzwari S, Hussain S, Islam M, Zaman M. General practitioners' awareness and management of common psychiatric disorders: a community-based survey from Karachi. Pak East Mediterr Health J. 2012;18:446\u201353.","journal-title":"Pak East Mediterr Health J"},{"key":"915_CR62","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1034\/j.1600-0579.2003.00212.x","volume":"51","author":"RR Aparasu","year":"2003","unstructured":"Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc. 2003;51:671\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"915_CR63","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1017\/S0714980810000115","volume":"29","author":"P Voyer","year":"2010","unstructured":"Voyer P, Pr\u00e9ville M, Cohen D, Berbiche D, B\u00e9land SG. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging. 2010;29:205\u201313.","journal-title":"Can J Aging"},{"key":"915_CR64","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00127-011-0344-1","volume":"47","author":"CM Sonnenberg","year":"2012","unstructured":"Sonnenberg CM, Bierman EJ, Deeg DJ, Comijs HC, van Tilburg W, Beekman AT. Ten-year trends in benzodiazepine use in the Dutch population. Soc Psychiatr Psychiatr Epidemiol. 2012;47:293\u2013301.","journal-title":"Soc Psychiatr Psychiatr Epidemiol"},{"key":"915_CR65","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/pds.4551","volume":"27","author":"T Kurko","year":"2018","unstructured":"Kurko T, Saastamoinen LK, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, et al. Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiol Drug Saf. 2018;27:674\u201382.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"915_CR66","first-page":"137","volume":"66","author":"M Vlastelica","year":"2012","unstructured":"Vlastelica M, Jelaska M. Za\u0161to su benzodiazepini jo\u0161 uvijek u \u0161irokoj primjeni? Acta Med Croatica. 2012;66:137\u201340.","journal-title":"Acta Med Croatica"},{"key":"915_CR67","unstructured":"Innovative Pharmaceutical Initiative: Drug policy in Croatia. Attitudes toward drug expenditure rationalization. 2013. https:\/\/ifi.hr\/wp-content\/uploads\/2017\/09\/carpc-ifi-drug-policy-in-croatia.pdf . Accessed 12 Sep 2018."},{"issue":"5","key":"915_CR68","doi-asserted-by":"publisher","first-page":"152","DOI":"10.18773\/austprescr.2015.055","volume":"38","author":"J Brett","year":"2015","unstructured":"Brett J, Murnion B. Management of benzodiazepine misuse and dependence. Aust Prescr. 2015;38(5):152\u20135.","journal-title":"Aust Prescr"},{"key":"915_CR69","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11096-017-0452-4","volume":"39","author":"A Millar","year":"2017","unstructured":"Millar A, Hughes C, Ryan C. Evaluating the prevalence of potentially inappropriate prescribing in older adults in intermediate care facilities: a cross-sectional observational study. Int J Clin Pharm. 2017;39:527\u201335.","journal-title":"Int J Clin Pharm"},{"key":"915_CR70","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00002018-199309020-00003","volume":"9","author":"S Marriott","year":"1993","unstructured":"Marriott S, Tyrer P. Benzodiazepine dependence: Avoidance and withdrawal. Drug Saf. 1993;9:93\u2013103.","journal-title":"Drug Saf"},{"key":"915_CR71","first-page":"964","volume":"56","author":"AN Siriwardena","year":"2006","unstructured":"Siriwardena AN, Qureshi Z, Gibson S, Collier S, Latham M. GPs\u2019 attitudes to benzodiazepine and \u201cZ-drug\u201d prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract. 2006;56:964\u20137.","journal-title":"Br J Gen Pract"},{"key":"915_CR72","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169.","journal-title":"BMJ"},{"key":"915_CR73","first-page":"2124","volume":"53","author":"N Cimolai","year":"2007","unstructured":"Cimolai N. Zopiclone: is it a pharmacologic agent for abuse? Can Fam Physician. 2007;53:2124\u20139.","journal-title":"Can Fam Physician"},{"key":"915_CR74","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00228-014-1667-0","volume":"70","author":"B Popovi\u0107","year":"2014","unstructured":"Popovi\u0107 B, Quadranti NR, Matanovi\u0107 SM, Lisica ID, Ljubotina A, Duliba DP, et al. Potentially inappropriate prescribing in elderly outpatients in Croatia. Eur J Clin Pharmacol. 2014;70:737\u201344.","journal-title":"Eur J Clin Pharmacol"},{"key":"915_CR75","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.lpm.2018.10.004","volume":"47","author":"M Tournier","year":"2018","unstructured":"Tournier M, Pariente A, B\u00e9gaud B, B\u00e9nard-Laribi\u00e8re A. Use and misuse of benzodiazepines out of France. Presse Med. 2018;47:882\u20135.","journal-title":"Presse Med"},{"key":"915_CR76","first-page":"253","volume":"129","author":"J \u010culig","year":"2007","unstructured":"\u010culig J, Leppee M, \u0160timac D, Kuva\u010di\u0107 I, Pulani\u0107-Klepac T, Herman R, et al. Presje\u010dno istra\u017eivanje uporabe lijekova u trudno\u0107i. Lijec Vjesn. 2007;129:253\u20139.","journal-title":"Lijec Vjesn"},{"key":"915_CR77","first-page":"214","volume":"13","author":"CE Griffin 3rd","year":"2013","unstructured":"Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13:214\u201323.","journal-title":"Ochsner J"},{"key":"915_CR78","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00228-004-0747-y","volume":"60","author":"V Vlahovi\u0107-Palcevski","year":"2004","unstructured":"Vlahovi\u0107-Palcevski V, Bergman U. Quality of prescribing for the elderly in Croatia-computerized pharmacy data can be used to screen for potentially inappropriate prescribing. Eur J Clin Pharmacol. 2004;60:217\u201320.","journal-title":"Eur J Clin Pharmacol"},{"key":"915_CR79","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/pds.940","volume":"13","author":"N Divac","year":"2004","unstructured":"Divac N, Jasovi\u0107 M, Djuki\u0107 L, Vujnovi\u0107 M, Babi\u0107 D, Bajceti\u0107 M, et al. Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia. Pharmacoepidemiol Drug Saf. 2004;13:315\u201322.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"915_CR80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3889\/oamjms.2015.004","volume":"3","author":"T Petrushevska","year":"2015","unstructured":"Petrushevska T, Stefanovska VV. Use of Medicines from the Group of Benzodiazepines in the Period of 2003\u20132013 Year in the Republic of Macedonia. Open Access Maced J Med Sci. 2015;3:151\u20137.","journal-title":"Open Access Maced J Med Sci"},{"key":"915_CR81","doi-asserted-by":"publisher","first-page":"e1002635","DOI":"10.1371\/journal.pmed.1002635","volume":"15","author":"A Sidorchuk","year":"2018","unstructured":"Sidorchuk A, Isomura K, Molero Y, Hellner C, Lichtenstein P, Chang Z, et al. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study. PLoS Med. 2018;15:e1002635.","journal-title":"PLoS Med"},{"key":"915_CR82","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40266-014-0205-1","volume":"31","author":"HC Ndukwe","year":"2014","unstructured":"Ndukwe HC, Tordoff JM, Wang T, Nishtala PS. Psychotropic medicine utilization in older people in New Zealand from 2005 to 2013. Drugs Aging. 2014;31:755\u201368.","journal-title":"Drugs Aging"},{"key":"915_CR83","first-page":"S37","volume":"38","author":"M Rapi\u0107","year":"2014","unstructured":"Rapi\u0107 M, Cika\u010d T, Bari\u0161i\u0107-Mar\u010dac Z, \u0160timac D. Trends in psychotropic drug utilization in Croatia. Coll Antropol. 2014;38:S37\u2013S42.","journal-title":"Coll Antropol"},{"key":"915_CR84","first-page":"14","volume":"4","author":"D \u0160timac","year":"2007","unstructured":"\u0160timac D, Vuku\u0161i\u0107 I, \u010culig J, \u0160ostar Z. Comparison of outpatient utilization of psychopharmaceuticals between Croatia and Scandinavian countries (2001\u20132003). Medicinski Glasnik. 2007;4:14\u201320.","journal-title":"Medicinski Glasnik"},{"key":"915_CR85","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000489538","volume":"87","author":"R Balon","year":"2018","unstructured":"Balon R, Chouinard G, Cosci F, Dubovsky SL, Fava GA, Freire RC, et al. International task force on benzodiazepines. Psychother Psychosom. 2018;87:193\u20134.","journal-title":"Psychother Psychosom"},{"key":"915_CR86","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0269881113503509","volume":"27","author":"DS Baldwin","year":"2013","unstructured":"Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, et al. Benzodiazepines: risks and benefits. A reconsideration. J Psychopharmacol. 2013;27:967\u201371.","journal-title":"J Psychopharmacol"},{"key":"915_CR87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jsr.2014.09.001","volume":"51","author":"LJ Paulozzi","year":"2014","unstructured":"Paulozzi LJ, Mack KA, Hockenberry JM. Variation among states in prescribing of opioid pain relievers and benzodiazepines\u2013United States, 2012. J Safety Res. 2014;51:125\u20139.","journal-title":"J Safety Res"},{"key":"915_CR88","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/14737167.2018.1507820","volume":"18","author":"I Poto\u010dnjak","year":"2018","unstructured":"Poto\u010dnjak I, Liki\u0107 R, Degoricija V, Nham E, Wettermark B. The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014\u20132015. Expert Rev Pharmacoecon Outcomes Res. 2018;18:641\u20136.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"915_CR89","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.3399\/bjgp16X685213","volume":"66","author":"CF Johnson","year":"2016","unstructured":"Johnson CF, Frei C, Downes N, McTaggart SA, Akram G. Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study. Br J Gen Pract. 2016;66:e410\u2013e415415.","journal-title":"Br J Gen Pract"},{"key":"915_CR90","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1192\/bjp.182.6.498","volume":"182","author":"RC Voshaar","year":"2003","unstructured":"Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, van de Lisdonk EH, Breteler MH, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatr. 2003;182:498\u2013504.","journal-title":"Br J Psychiatr"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00915-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-019-00915-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00915-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T05:36:32Z","timestamp":1664602592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-019-00915-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1007\/s11096-019-00915-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,8]]},"assertion":[{"value":"23 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors received no funding for this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors declare that they have no conflict of interest regarding the work presented in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}